Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kaufmann

Showing results (681-690 of 720) with videos related to

Pageof 72
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 28, 2010
First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trialM Kaufmann, N Maass, S D Costa, et al.
International Journal of Cancer|May 5, 2017
Human papillomavirus E7 protein detection as a method of triage to colposcopy of HPV positive women, in comparison to genotyping and cytology. Final results of the PIPAVIR studyTheodoros Agorastos, Kimon Chatzistamatiou, Theodoros Moysiadis, et al.
Ecancermedicalscience|October 18, 2024
Prevalence of human papillomaviruses in self-collected samples among women attending antenatal care in Ethiopia: a cross-sectional studyIsabel Runge, Johanna M A Klein, Ann-Katrin Pannen, et al.
Neurosurgery|April 3, 2018
Stereotactic Radiosurgery for Intracranial Ependymomas: An International Multicenter StudyHideyuki Kano, Yan-Hua Su, Hsiu-Mei Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study GroupM Kaufmann, E Bajetta, L Y Dirix, et al.
Clinical Breast Cancer|April 24, 2002
Exemestane improves survival in metastatic breast cancer: results of a phase III randomized studyM Kaufmann, E Bajetta, L Y Dirix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2007
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006M Kaufmann, G von Minckwitz, H D Bear, et al.
Zentralblatt Fur Gynakologie|December 26, 2001
[Preoperative chemotherapy in primary operable breast cancer with a dose-dense combination of doxorubicin and docetaxel (ADoc) - Experience of the GEPARDO-GABG study group]G von Minckwitz, G Raab, M Schütte, et al.
Microorganisms|April 28, 2023
Cervicovaginal Microbiota Profiles in Precancerous Lesions and Cervical Cancer among Ethiopian WomenBrhanu Teka, Kyoko Yoshida-Court, Ededia Firdawoke, et al.
The Clinical Neuropsychologist|January 19, 2022
Official position of the American Academy of Clinical Neuropsychology on test securityKyle Brauer Boone, Jerry J Sweet, Desiree A Byrd, et al.
Pageof 72

Showing results (681-690 of 720) with videos related to

Sort By:
Pageof 72
European Journal of Cancer (Oxford, England : 1990)|August 28, 2010
First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trialM Kaufmann, N Maass, S D Costa, et al.
International Journal of Cancer|May 5, 2017
Human papillomavirus E7 protein detection as a method of triage to colposcopy of HPV positive women, in comparison to genotyping and cytology. Final results of the PIPAVIR studyTheodoros Agorastos, Kimon Chatzistamatiou, Theodoros Moysiadis, et al.
Ecancermedicalscience|October 18, 2024
Prevalence of human papillomaviruses in self-collected samples among women attending antenatal care in Ethiopia: a cross-sectional studyIsabel Runge, Johanna M A Klein, Ann-Katrin Pannen, et al.
Neurosurgery|April 3, 2018
Stereotactic Radiosurgery for Intracranial Ependymomas: An International Multicenter StudyHideyuki Kano, Yan-Hua Su, Hsiu-Mei Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study GroupM Kaufmann, E Bajetta, L Y Dirix, et al.
Clinical Breast Cancer|April 24, 2002
Exemestane improves survival in metastatic breast cancer: results of a phase III randomized studyM Kaufmann, E Bajetta, L Y Dirix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2007
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006M Kaufmann, G von Minckwitz, H D Bear, et al.
Zentralblatt Fur Gynakologie|December 26, 2001
[Preoperative chemotherapy in primary operable breast cancer with a dose-dense combination of doxorubicin and docetaxel (ADoc) - Experience of the GEPARDO-GABG study group]G von Minckwitz, G Raab, M Schütte, et al.
Microorganisms|April 28, 2023
Cervicovaginal Microbiota Profiles in Precancerous Lesions and Cervical Cancer among Ethiopian WomenBrhanu Teka, Kyoko Yoshida-Court, Ededia Firdawoke, et al.
The Clinical Neuropsychologist|January 19, 2022
Official position of the American Academy of Clinical Neuropsychology on test securityKyle Brauer Boone, Jerry J Sweet, Desiree A Byrd, et al.
Pageof 72